A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing (VoriTDM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Johns Hopkins University
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Kieren Marr, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01416025
First received: August 11, 2011
Last updated: March 18, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)